Start your free 3-day trial — no credit card required, full access included

Evidence - Open rectal resection, low anterior with total mesorectal excision (TME)

  1. Summary of the Literature

    Definition of Colon and Rectum Carcinoma

    According to the international documentation system, rectal carcinomas are tumors whose aboral margin, when measured with the rigid rectoscope, is 16 cm or less from the anocutaneous line [1, 2]. A distinction is made between

    • the lower third (0–6 cm),
    • the middle third (6–12 cm) and
    • the upper third (12–16 cm) [3].

    In the USA, on the other hand, tumors up to 12 cm and less from the linea anocutanea are referred to as rectal carcinomas, above the 12 cm limit they are counted as colon carcinomas [4].

     

    Abbreviated TNM Classification of Colorectal Carcinomas [5]

    StageTNM

    Depth of Infiltration/Tumor Spread

     

    IT1N0

    Submucosa

     

     T2N0Muscularis propria
    IIT3N0Perirectal tissue: Mesorectum
     T4N0

    T4a   Visceral peritoneum

    T4b   Other organs/structures

     

    IIIN1/2

    N1a   1 regional lymph node metastasis

    N1b   2–3 regional lymph node metastases

    N1c   Satellites/tumor nodules in the mesorectum

    N2a   4–6 regional lymph nodes

    N2b   >6 regional lymph nodes

     

    IVM1

    M1a   Metastases limited to one organ (liver, lung, ovary,  non-regional lymph nodes, no peritoneal metastases)

    M1b   Metastases in more than one organ

    M1c   Metastases in the peritoneum with/without metastases in other organs

                                                                  

    Interdisciplinary Tumor Conference

    Due to the complex therapy, all colorectal carcinomas should ideally be presented before therapy (e.g. surgery, chemotherapy) in an interdisciplinary tumor conference to create a joint treatment concept. In a study from Great Britain, patient survival could be significantly increased as a result [6].

    A pre-therapeutic conference is particularly recommended for

    • every rectal carcinoma
    • every colon carcinoma in stage IV
    • distant metastases
    • local recurrences
    • before every local ablative measure

    In rectal carcinoma, for example, it can be clarified whether a neoadjuvant radiochemotherapy should be carried out. In one study, the rate of affected circumferential margin in the surgical specimen could also be significantly reduced through pre-therapeutic case discussions [7]. If distant metastases are already present, it can be clarified whether a palliative/ablative concept is to be carried out or whether the distant metastases (e.g. liver metastases) are to be resected in one or two stages.  Patients with distant metastases in whom chemotherapy was primarily initiated should be presented again to clarify whether secondary resectability of the metastases is possible. The rate of metastasis surgery has increased through the repeated presentation of patients in tumor conferences [8].

     

    Preoperative Staging Diagnostics

    The staging of rectal carcinoma includes

    • complete colonoscopy, if necessary biopsy for secondary tumors
    • abdominal sonography
    • chest X-ray
    • rigid rectoscopy with if necessary biopsy and height indication
    • MRI pelvis with indication of the distance of the tumor to the mesorectal fascia 
    • Alternative to MRI rectal endosonography

    A rectal-digital examination is also obligatory (assessment of sphincter function, estimation of sphincter preservation in low rectal carcinomas).

     In 5 % of colorectal carcinomas, secondary tumors are to be expected. Therefore, a complete colonoscopy should be performed preoperatively [9, 10, 11]. If this is not possible due to a stenosing tumor, preoperative imaging procedures should be considered (CT or MR colonography) [12]. Regardless of the imaging diagnostics, a colonoscopy should be performed 3 - 6 months after resection in these cases.

    At the time of initial diagnosis of a rectal carcinoma, the frequency of distant metastases is 18 %. Distant metastases are found in 14 % of cases in the liver, lung metastases in 4 %, peritoneal metastases in 3 %, in non-regional lymph nodes in 2 %. To clarify liver metastases, abdominal sonography and a CT of the abdomen are performed as basic diagnostics [13, 14].

    At the time of initial diagnosis, the tumor marker CEA is elevated in about 30 % of all colorectal carcinomas and should therefore be determined preoperatively. In tumor follow-up, CEA is a reliable indication of recurrence in marker-expressing tumors and is also an independent prognostic factor in the case of liver metastases. The significance of CA 125 as a progression parameter for further treatment of proven peritoneal carcinomatosis is currently unclear [15, 16, 17].

     

    Significance of Local Staging in Rectal Carcinoma

    In rectal carcinoma, local staging is of decisive importance for further therapy planning:

    low risk T1 carcinoma:local removal
    high risk T1- and T2 carcinoma:resection according to oncological criteria
    T3 = infiltration of the mesorectum:neoadjuvant therapy
    T4 = infiltration into neighboring organs:neoadjuvant radiochemotherapy

    For T3 carcinomas, data show that the extent of mesorectum infiltration (in particular the distance from the mesorectal fascia) is of important prognostic significance [18]. In total mesorectal excision (TME), this plane represents the circumferential resection margin (CRM).  If the carcinoma reaches up to 1 mm to the fascia or has already infiltrated it (CRM+), the risk of local recurrences is significantly increased [18]. Another prognostic factor is lymph node involvement [19].

    In a meta-analysis from 2004, in which the data on endosonography, MRI and CT up to 2002 were analyzed, sonography showed the highest accuracy for T1 carcinomas [20], which was confirmed in a more recent meta-analysis [21]. An alternative to endosonography is MRI with endorectal coil (more expensive, unpleasant for patients, hardly available). Compared to MRI and CT, endosonography again showed higher sensitivity in differentiating T2- and T3 carcinomas [20], whereas for T4 carcinomas there is no significant difference between the various imaging procedures. For the depiction of the mesorectal fascia  and its relationship to the tumor, MRI shows the highest sensitivity [22]. Spiral CT is an alternative for assessing the fascia [23], in endosonography the fascia is not depicted.

     

    Radical Surgical Therapy of Rectal Carcinoma

    The curative, radical resection of rectal carcinoma usually includes the resection of the primary tumor in healthy tissue as well as the partial or total removal of the mesorectum and thus of the regional lymphatic drainage area [24]. Only in strictly selected cases is curative resection possible through local measures (full-wall excision).

    If the criteria of oncological surgery are adhered to, the following surgical procedures are to be regarded as equivalent depending on tumor location, relationship to the linea dentata and levator sling, depth infiltration and sphincter function:

    • low anterior rectal resection
    • abdominoperineal rectal extirpation
    • intersphincteric rectal resection (abdominoperanal rectal resection)

    Oncological Principles:

    1. Removal of the regional lymphatic drainage area with ligation of the inferior mesenteric artery at least distal to the origin of the left colic artery. The value of lymph node dissection at the trunk of the inferior mesenteric artery proximal to the origin of the left colic artery is not established [25 -  28]. The same applies  to the dissection of the lateral lymph nodes along the internal iliac artery including its branches [31 - 34].

    2. Complete removal of the mesorectum (TME) in carcinoma of the middle and lower rectal third and partial mesorectum excision in carcinoma of the upper rectal third by sharp dissection between fascia pelvis visceralis and parietalis  along anatomical structures [29, 30].

    3. Maintenance of an appropriate safety margin

    • Upper rectal third : horizontal ligation of the rectum with partial mesorectum excision 5 cm distal to the macroscopic tumor margin [29, 36 - 39]*
    • Middle and lower rectal third: TME to the pelvic floor with sparing of the superior hypogastric plexus, the hypogastric nerves and the inferior hypogastric plexus [40 - 42] 

             -> Low-Grade-TU good or moderate differentiation in the lower third Safety margin of 1-2 cm sufficient

             -> for High-Grade-TU > 2 cm [43 - 47]

    * Justification: In T3- and T4-tumors, satellite nodules or lymph node metastases can rarely occur up to 4 cm distal to the macroscopic tumor margin.

     

    Reconstruction after Total Mesorectal Excision

    After TME with subsequent sphincter-near anastomosis, the following reconstruction procedures are considered:

    • straight colo-anal anastomosis
    • Colon-J-Pouch
    • transverse coloplasty
    • side-to-end anastomosis

    Straight colo-anal anastomoses lead to increased stool frequency as well as poorer continence and quality of life, especially in the first two postoperative years, and are therefore not recommended [48]. The advantages of the Colon-J-Pouch in terms of functional outcome are best documented [48, 49].  To avoid evacuation problems, the limb length should not exceed 6 cm when creating the J-Pouch [50]. In almost 75 % of cases, the creation of a J-Pouch is technically possible [49]. From a functional point of view, the side-to-end anastomosis is probably equivalent to the Colon-J-Pouch [51], the transverse coloplasty is inferior to the pouch [52].

     

    Stoma Creation

    In radical surgery of rectal carcinoma with TME and deep anastomosis, a temporary stoma should be placed upstream. This can reduce morbidity (anastomotic leaks, urgent relaparotomies) [53]. Colostomy and ileostomy are considered equivalent, although current meta-analyses favor the ileostomy [54, 55]. The stoma position should be marked preoperatively. The ileostomy should be created prominently (> 1 cm), the colostomy slightly elevated.

     

    Local Surgical Procedures for Rectal Carcinoma

    Local tumor excision (full-wall excision) as a sole measure with curative intent (R0 resection) is oncologically sufficient for pT1 carcinomas under the following conditions [56 - 59]:

    • maximum tumor diameter 3 cm
    • good or moderate differentiation
    • no lymph vessel invasion (low-risk histology)

    Compared to radical surgery, even in low-risk cases, a higher risk of local recurrences is to be expected with simultaneously lower morbidity and lethality, so that these risks must be weighed against each other [60, 61]. Studies indicate that the technique of transanal endoscopic microsurgery is superior to open transanal excision using retractors [62, 63].

    In T1 high-risk carcinomas (G3/4 and/or lymph vessel invasion) and in T2 carcinomas, the occurrence of lymph node metastases is 10 - 20 %, so that local excision alone is not recommended [64, 65].

     

    Laparoscopic Surgery

    With appropriate expertise of the surgeon and suitable selection, laparoscopic resection of a colorectal carcinoma can be performed with the same oncological results compared to the open surgical procedure. In the short-term course, perioperative morbidity is lower with minimally invasive procedures with unchanged overall morbidity and lethality [66]. In the long-term course, no differences were found between laparoscopic and conventional surgery for the rate of incisional hernias and adhesion-related relaparotomies nor for tumor recurrences [67, 68]. The British CLASSIC study also confirms the oncological safety of laparoscopic surgery for colorectal carcinomas [69, 70].

  2. Currently ongoing studies on this topic

  3. Literature on this topic

    1. Fielding, L.P., et al., Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol, 1991. 6(4): p. 325-44.

    2. Soreide, O., et al., International standardization and documentation of the treatment of rectal cancer., in Rectal cancer surgery. Optimisation - standardization - documentation., O. Soreide and J. Norstein, Editors. 1997, Springer: Berlin Heidelberg New York. p. 405-45.

    3. UICC, TNM Classification of Malignant Tumours. 6th Edition ed, ed. L.H. Sobin and C. Wittekind. 2002, New York: John Wiley & Sons.

    4. Pilipshen, S.J., et al., Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer, 1984. 53(6): p. 1354-62.

    5. Wittekind (Ed.) (2017) TNM Classification of Malignant Tumors. 8th Ed. Wiley-VCH, Weinheim

    6. MacDermid, E., et al., Improving patient survival with the colorectal cancer multi-disciplinary team. Colorectal Dis, 2009. 11(3): p. 291-5.

    7. Burton, S., et al., MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer, 2006. 94(3): p. 351-7.

    8. Segelman, J., et al., Differences in multidisciplinary team assessment and treatment between patients with stage IV colon and rectal cancer. Colorectal Dis, 2009. 11(7): p. 768-74.

    9. Barillari, P., et al., Effect of preoperative colonoscopy on the incidence of synchronous and metachronous neoplasms. Acta Chir Scand, 1990. 156(2): p. 163-6. 646.

    10. Faivre, J., [Endoscopic monitoring after excision of colorectal cancer]. J Chir (Paris), 1997. 134(7-8): p. 283-5. 647.

    11. Chen, H.S. and S.M. Sheen-Chen, Synchronous and "early" metachronous colorectal adenocarcinoma: analysis of prognosis and current trends. Dis Colon Rectum, 2000. 43(8): p. 1093-9.

    12. Neri, E., et al., Colorectal cancer: role of CT colonography in preoperative evaluation after incomplete colonoscopy. Radiology, 2002. 223(3): p. 615-9.

    13. Floriani, I., et al., Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis. J Magn Reson Imaging, 2010. 31(1): p. 19-31.

    14. Niekel, M.C., S. Bipat, and J. Stoker, Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology, 2010. 257(3): p. 674-84.

    15. Levy, M., et al., Tumor markers in staging and prognosis of colorectal carcinoma. Neoplasma, 2008. 55(2): p. 138-42.

    16. Lewis, M.R., et al., Metastatic colorectal adenocarcinoma involving the ovary with elevated serum CA125: a potential diagnostic pitfall. Gynecol Oncol, 2007. 105(2): p. 395-8.

    17. Chen, C.C., et al., Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? J Surg Res, 2005. 124(2): p. 169-74.

    18. Merkel, S., et al., The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis, 2001. 16(5): p. 298-304.

    19. Nagtegaal, I.D. and P. Quirke, What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol, 2008. 26(2): p. 303-12.

    20. Bipat, S., et al., Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis. Radiology, 2004. 232(3): p. 773-83.

    21. Puli, S.R., et al., Accuracy of endoscopic ultrasound to diagnose nodal invasion by rectal cancers: a meta-analysis and systematic review. Ann Surg Oncol, 2009. 16(5): p. 1255-65.

    22. Purkayastha, S., et al., Magnetic resonance colonography vs computed tomography colonography for the diagnosis of colorectal cancer: an indirect comparison. Colorectal Dis, 2007. 9(2): p. 100-11.

    23. Ahmetoglu, A., et al., MDCT with multiplanar reconstruction in the preoperative local staging of rectal tumor. Abdom Imaging, 2011. 36(1): p. 31-7.

    24. Ahmetoglu, A., et al., MDCT with multiplanar reconstruction in the preoperative local staging of rectal tumor. Abdom Imaging, 2011. 36(1): p. 31-7.

    25. Pezim, M.E. and R.J. Nicholls, Survival after high or low ligation of the inferior mesenteric artery during curative surgery for rectal cancer. Ann Surg, 1984. 200(6): p. 729-33.

    26. Surtees, P., J.K. Ritchie, and R.K. Phillips, High versus low ligation of the inferior mesenteric artery in rectal cancer. Br J Surg, 1990. 77(6): p. 618-21

    27. Slanetz, C.A., Jr. and R. Grimson, Effect of high and intermediate ligation on survival and recurrence rates following curative resection of colorectal cancer. Dis Colon Rectum, 1997. 40(10): p. 1205-18; discussion 1218-9.

    28. Lange, M.M., et al., Level of arterial ligation in rectal cancer surgery: low tie preferred over high tie. A review. Dis Colon Rectum, 2008. 51(7): p. 1139-45.

    29. Heald, R.J., E.M. Husband, and R.D. Ryall, The mesorectum in rectal cancer surgery--the clue to pelvic recurrence? Br J Surg, 1982. 69(10): p. 613-6.

    30. Bokey, E.L., et al., Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: role of total anatomical dissection. Br J Surg, 1999. 86(9): p. 1164-70.

    31. Georgiou, P., et al., Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol, 2009. 10(11): p. 1053-62.

    32. Gohl, J., W. Hohenberger, and S. Merkel, Lymph node dissection in rectal carcinoma: TME and what else? Onkologie, 2009. 32(1-2): p. 57-61.

    33. Mortenson, M.M., et al., Total mesorectal excision and pelvic node dissection for rectal cancer: an appraisal. Surg Oncol Clin N Am, 2007. 16(1): p. 177-97.

    34. Koch, M., et al., Is the lateral lymph node compartment relevant? Recent Results Cancer Res, 2005. 165: p. 40-5.

    35. Scott, N., et al., Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg, 1995. 82(8): p. 1031-3.

    36. Reynolds, J.V., et al., Pathological evidence in support of total mesorectal excision in the management of rectal cancer. Br J Surg, 1996. 83(8): p. 1112-5. 735.

    37. Hida, J., et al., Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method: justification of total mesorectal excision. J Am Coll Surg, 1997. 184(6): p. 584-8. 736.

    38. Zaheer, S., et al., Surgical treatment of adenocarcinoma of the rectum. Ann Surg, 1998. 227(6): p. 800-11. 737.

    39. Leong, A.F., Selective total mesorectal excision for rectal cancer. Dis Colon Rectum, 2000. 43(9): p. 1237-40.

    40. Havenga, K., et al., Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg, 1996. 182(6): p. 495-502

    41. Heald, R.J. and N.D. Karanjia, Results of radical surgery for rectal cancer. World J Surg, 1992. 16(5): p. 848-57.

    42. Enker, W.E., Total mesorectal excision--the new golden standard of surgery for rectal cancer. Ann Med, 1997. 29(2): p. 127-33.

    43. Bokey, E.L., et al., Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: role of total anatomical dissection. Br J Surg, 1999. 86(9): p. 1164-70.

    44. Lazorthes, F., et al., Distal intramural spread of carcinoma of the rectum correlated with lymph nodal involvement. Surg Gynecol Obstet, 1990. 170(1): p. 45-8. 741.

    45. Kwok, S.P., et al., Prospective analysis of the distal margin of clearance in anterior resection for rectal carcinoma. Br J Surg, 1996. 83(7): p. 969-72. 742.

    46. Andreola, S., et al., Distal intramural spread in adenocarcinoma of the lower third of the rectum treated with total rectal resection and coloanal anastomosis. Dis Colon Rectum, 1997. 40(1): p. 25-9. 743.

    47. Goldstein, N.S., A. Soman, and J. Sacksner, Disparate surgical margin lengths of colorectal resection specimens between in vivo and in vitro measurements. The effects of surgical resection and formalin fixation on organ shrinkage. Am J Clin Pathol, 1999. 111(3): p. 349-51.

    48. Brown, C.J., D.S. Fenech, and R.S. McLeod, Reconstructive techniques after rectal resection for rectal cancer. Cochrane Database Syst Rev, 2008(2): p. CD006040.

    49. Fazio, V.W., et al., A randomized multicenter trial to compare long-term functional outcome, quality of life, and complications of surgical procedures for low rectal cancers. Ann Surg, 2007. 246(3): p. 481-8; discussion 488-90.

    50. Hida, J., et al., Functional outcome after low anterior resection with low anastomosis for rectal cancer using the colonic J-pouch. Prospective randomized study for determination of optimum pouch size. Dis Colon Rectum, 1996. 39(9): p. 986-91.

    51. Siddiqui, M.R., et al., A meta-analysis comparing side to end with colonic J-pouch formation after anterior resection for rectal cancer. Tech Coloproctol, 2010. 14(2): p. 113-23.

    52. Liao, C., et al., Meta-analysis of the colon J-pouch vs transverse coloplasty pouch after anterior resection for rectal cancer. Colorectal Dis, 2010. 12(7): p. 624-31.

    53. Montedori, A., et al., Covering ileo- or colostomy in anterior resection for rectal carcinoma. Cochrane Database Syst Rev, 2010(5): p. CD006878.

    54. Klink, C.D., et al., [Protective ileostoma versus protective transverse stoma. What evidence is available?]. Chirurg, 2010. 81(11): p. 974-7.

    55. Rondelli, F., et al., Loop ileostomy versus loop colostomy for fecal diversion after colorectal or coloanal anastomosis: a meta-analysis. Int J Colorectal Dis, 2009. 24(5): p. 479-88.

    56. Hermanek, P. and G.P. Marzoli, Local Therapy of Rectal Carcinoma. Procedures with Curative Intent. 1994, Berlin Heidelberg New York Tokyo: Springer.

    57. Winde, G., et al., Surgical cure for early rectal carcinomas (T1). Transanal endoscopic microsurgery vs. anterior resection. Dis Colon Rectum, 1996. 39(9): p. 969-76.

    58. Sengupta, S. and J.J. Tjandra, Local excision of rectal cancer: what is the evidence? Dis Colon Rectum, 2001. 44(9): p. 1345-61. 767.

    59. Matzel, K.E., S. Merkel, and W. Hohenberger, Local Therapy Principles in Rectal Carcinoma. Chirurg, 2003. 74(10): p. 897-904.

    60. Ptok, H., et al., Oncological outcome of local vs radical resection of low-risk pT1 rectal cancer. Arch Surg, 2007. 142(7): p. 649-55; discussion 656.

    61.  You, Y.N., et al., Is the increasing rate of local excision for stage I rectal cancer in the United States justified?:  a nationwide cohort study from the National Cancer Database. Ann Surg, 2007. 245(5): p. 726-33

    62. Moore, J.S., et al., Transanal endoscopic microsurgery is more effective than traditional transanal excision for resection of rectal masses. Dis Colon Rectum, 2008. 51(7): p. 1026-30; discussion 1030-1.

    63. Sgourakis, G., et al., Transanal endoscopic microsurgery for T1 and T2 rectal cancers: a metaanalysis and meta-regression analysis of outcomes. Am Surg, 2011. 77(6): p. 761-72.

    64. Bach, S.P., et al., A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer. Br J Surg, 2009. 96(3): p. 280-90

    65. Hahnloser, D., et al., Immediate radical resection after local excision of rectal cancer: an oncologic compromise? Dis Colon Rectum, 2005. 48(3): p. 429-37.

    66. Schwenk, W., et al., Short term benefits for laparoscopic colorectal resection. Cochrane Database Syst Rev, 2005(3): p. CD003145

    67. Liang, Y., et al., Laparoscopic versus open colorectal resection for cancer: a meta-analysis of results of randomized controlled trials on recurrence. Eur J Surg Oncol, 2008. 34(11): p. 121724.

    68.  Kuhry, E., et al., Long-term results of laparoscopic colorectal cancer resection. Cochrane Database Syst Rev, 2008(2): p. CD003432.

    69. Guillou, P.J., et al., Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet, 2005. 365(9472): p. 1718-26.

    70. Jayne, D.G., et al., Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg, 2010. 97(11): p. 1638-45.

  4. Reviews

    Alimova I, Chernyshov S, Nagudov M, Rybakov E. Comparison of oncological and functional outcomes and quality of life after transanal or laparoscopic total mesorectal excision for rectal cancer: a systematic review and meta-analysis. Tech Coloproctol. 2021 Aug;25(8):901-913.

    An Y, Roodbeen SX, Talboom K, Tanis PJ, Bemelman WA, Hompes R. A systematic review and meta-analysis on complications of transanal total mesorectal excision. Colorectal Dis. 2021 Oct;23(10):2527-2538.

    Anania G, Davies RJ, Arezzo A, Bagolini F, D'Andrea V, Graziosi L, Di Saverio S, Popivanov G, Cheruiyot I, Cirocchi R, Donini A. Rise and fall of total mesorectal excision with lateral pelvic lymphadenectomy for rectal cancer: an updated systematic review and meta-analysis of 11,366 patients. Int J Colorectal Dis. 2021 Nov;36(11):2321-2333.

    Burghgraef TA, Sikkenk DJ, Verheijen PM, Moumni ME, Hompes R, Consten ECJ. The learning curve of laparoscopic, robot-assisted and transanal total mesorectal excisions: a systematic review. Surg Endosc. 2022 Sep;36(9):6337-6360.

    Butterworth JW, Butterworth WA, Meyer J, Giacobino C, Buchs N, Ris F, Scarpinata R. A systematic review and meta-analysis of robotic-assisted transabdominal total mesorectal excision and transanal total mesorectal excision: which approach offers optimal short-term outcomes for mid-to-low rectal adenocarcinoma? Tech Coloproctol. 2021 Nov;25(11):1183-1198.

    Choy KT, Yang TWW, Prabhakaran S, Heriot A, Kong JC, Warrier SK. Comparing functional outcomes between transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LaTME) for rectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis. 2021 Jun;36(6):1163-1174.

    Gang DY, Dong L, DeChun Z, Yichi Z, Ya L. A systematic review and meta-analysis of minimally invasive total mesorectal excision versus transanal total mesorectal excision for mid and low rectal cancer. Front Oncol. 2023 Jun 12;13:1167200.

    Gavriilidis P, Wheeler J, Spinelli A, de'Angelis N, Simopoulos C, Di Saverio S. Robotic vs laparoscopic total mesorectal excision for rectal cancers: has a paradigm change occurred? A systematic review by updated meta-analysis. Colorectal Dis. 2020 Nov;22(11):1506-1517.

    Hajibandeh S, Hajibandeh S, Eltair M, George AT, Thumbe V, Torrance AW, Budhoo M, Joy H, Peravali R. Meta-analysis of transanal total mesorectal excision versus laparoscopic total mesorectal excision in management of rectal cancer. Int J Colorectal Dis. 2020 Apr;35(4):575-593.

    Lo Bianco S, Lanzafame K, Piazza CD, Piazza VG, Provenzano D, Piazza D. Total mesorectal excision laparoscopic versus transanal approach for rectal cancer: A systematic review and meta-analysis. Ann Med Surg (Lond). 2022 Jan 24;74:103260.

    Longchamp G, Meyer J, Christou N, Popeskou S, Roos E, Toso C, Buchs NC, Ris F.Total mesorectal excision with and without lateral lymph node dissection: a systematic review of the literature. Int J Colorectal Dis. 2020 Jul;35(7):1183-1192.

    Milone M, Manigrasso M, Velotti N, Torino S, Vozza A, Sarnelli G, Aprea G, Maione F, Gennarelli N, Musella M, De Palma GD. Completeness of total mesorectum excision of laparoscopic versus robotic surgery: a review with a meta-analysis. Int J Colorectal Dis. 2019 Jun;34(6):983-991.

  5. Guidelines

  6. literature search

    Literature search on the pages of pubmed.